|
|
Prepublished online as a Blood First Edition Paper on May 22, 2003; DOI 10.1182/blood-2002-12-3634.
 Previous Article | Table of Contents | Next Article 
Blood, 15 September 2003, Vol. 102, No. 6, pp. 2099-2107
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3)
Tamar Licht,
Lilia Tsirulnikov,
Hadas Reuveni,
Talia Yarnitzky, and
Shmuel A. Ben-Sasson
From Keryx Biopharmaceuticals, Jerusalem, Israel; and the Department of Experimental Medicine and Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
The G-protein–coupled receptors of the endothelial differentiation gene (EDG) family mediate pro-angiogenic activities, such as endothelial cell proliferation, chemotaxis, and vessel morphogenesis. We synthesized and tested the effects of a 9-amino acid peptide (KRX-725), derived from the second intracellular loop of S1P3 (EDG3). KRX-725 mimics the effects of sphingosine 1-phosphate (S1P), the natural ligand of S1P3, by triggering a Gi-dependent MEK-ERK (mitogen-activated protein kinase kinase and extracellular signal-regulated kinase) signal transduction pathway. Using aortic rings as an ex vivo model of angiogenesis, vascular sprouting was assessed in the presence of KRX-725 or S1P. KRX-725 induced extensive and dense vascular sprouts, which contain an elaborated organization of endothelial and smooth muscle layers, including lumen formation. When KRX-725 or S1P was combined with proangiogenic factors, such as basic fibroblast growth factor (bFGF), stem cell factor, or vascular endothelial growth factor, the effect was synergistic, leading to further enhancement of vascular sprouting. KRX-725 also initiated neovascularization in a mouse corneal pocket assay in vivo and showed synergism with bFGF. The specificity of KRX-725 was demonstrated via peptide-induced receptor internalization of S1P3 but not S1P1. The ability of a short peptide to stimulate extensive angiogenesis and to synergize with pro-angiogenic factors suggests that KRX-725 may serve as a useful agent in treating pathologic conditions such as peripheral vascular disease, cardiac ischemia, or tissue grafts.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Sakao, L. Taraseviciene-Stewart, C. D. Cool, Y. Tada, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi, T. Kuriyama, et al.
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells
FASEB J,
November 1, 2007;
21(13):
3640 - 3652.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bonnaud, C. Niaudet, G. Pottier, M.-H. Gaugler, J. Millour, J. Barbet, L. Sabatier, and F. Paris
Sphingosine-1-Phosphate Protects Proliferating Endothelial Cells from Ceramide-Induced Apoptosis but not from DNA Damage-Induced Mitotic Death
Cancer Res.,
February 15, 2007;
67(4):
1803 - 1811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, et al.
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
275 - 282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Kaidanovich-Beilin and H. Eldar-Finkelman
Peptides Targeting Protein Kinases: Strategies and Implications.
Physiology,
December 1, 2006;
21(6):
411 - 418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Y. Niv, H. Rubin, J. Cohen, L. Tsirulnikov, T. Licht, A. Peretzman-Shemer, E. Cna'an, A. Tartakovsky, I. Stein, S. Albeck, et al.
Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification
J. Biol. Chem.,
January 9, 2004;
279(2):
1242 - 1255.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
